Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Siemens Healthineers Showcases Atellica Solution at AACC 2017

By LabMedica International staff writers
Posted on 07 Aug 2017
Siemens Healthineers (Erlangen, Germany), the separately managed healthcare business of Siemens AG, showcased the Atellica Solution – flexible, scalable, automation-ready immunoassay and chemistry analyzers for laboratory diagnostics – at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo, the world’s largest exposition for clinical laboratory products and services.

Siemens Healthineers offers a comprehensive portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. More...
The company was among over 750 exhibitors who displayed pioneering diagnostic technology, including the latest in mobile health, molecular diagnostics, mass spectrometry, point-of-care (POC), and automation at the 2017 AACC Clinical Lab Expo held at the San Diego Convention Center from August 1-3.

The recently 510(k)-cleared Atellica Solution is comprised of sample management and immunoassay and chemistry analyzer components. It can combine up to 10 components into more than 300 customizable configurations – including linear, L and U shapes. With an immunoassay analyzer that runs up to 440 tests per hour, the Atellica Solution is suitable for mid-and high-volume labs. The product was displayed as a stand-alone system at AACC 2017 and connected to Aptio Automation to demonstrate a comprehensive multi-disciplinary solution.

“Siemens Healthineers is driving healthcare forward in the digital age by delivering fast and easy interaction between data and knowledge, to go along with our complete in vivo and in vitro offerings,” said Michael Reitermann, Chief Operating Officer, Siemens Healthineers.
Siemens Healthineers also exhibited the Atellica Diagnostics IT family of products, which includes connectivity management, data management, inventory management, process management and clinical decision support for multi-site laboratories seeking real-time analytics to improve workflow and efficiency. Atellica Diagnostics IT features customizable parameters, performance-monitoring capabilities, and centralized control over the day-to-day laboratory operations to improve business and clinical outcomes.

“FDA clearance for the Atellica Solution opens the door for us to change the game in laboratory diagnostics with a revolutionary platform designed by customers for customers,” said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers. “Combined with the Atellica Solution, our highly integrated Atellica Diagnostics IT will simplify lab workflows to meet increasing testing demand.”

The company also showcased its complete POC informatics portfolio with offerings for secure connectivity to more than 160 devices from over 40 vendors. The solutions are designed to streamline operations and centrally manage all POCT devices.

“Open connectivity, regardless of the manufacturer, for point-of-care instruments addresses key pain points that previously challenged the implementation of point-of-care testing,” said Peter Koerte, President, Point of Care Diagnostics, Siemens Healthineers. “Further, the latest advances in connectivity provide POC coordinators valuable data for better decision-making to support improved patient outcomes.”

Siemens Healthineers’ informatics offerings include RAPIDComm Data Management System for managing and controlling POC testing programs, POCcelerator Software, which connects POCT devices from all manufacturers to a hospital’s IT system, and UniPOC Software, which seamlessly connects and manages POC devices from numerous manufacturers through a single enterprise platform for laboratories that prefer a vendor-independent approach.

Additionally, Siemens Healthineers celebrated the US launch of Xprecia Stride, a handheld portable coagulation analyzer for Prothrombin Time International Normalized Ratio (PT/INR) testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Blood Glucose Test Strip
AutoSense Test
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.